Top Markets
Coin of the day
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Rang in aandelen #25552
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Aandeelprijs
$20.01
Laatst gesynchroniseerd: 2025-02-21
Marktkapitalisatie
$48.36M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Singular Genomics Systems, Inc. (OMIC)

Categorie

Prijs OMIC met de marktkapitalisatie van B
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.
OMIC
$20.01
Marktkapitalisatie van Singular Genomics Systems, Inc.(OMIC)
Marktkapitalisatie: $48.36M
Vanaf August 2026 heeft Singular Genomics Systems, Inc. een marktkapitalisatie van $48.36M. Dit maakt Singular Genomics Systems, Inc. volgens onze gegevens het 25552nd meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Singular Genomics Systems, Inc. van 2021 tot 2026
OMIC vergeleken met de top 5 populairste stocks
Prijs voor OMIC Aandeel B Marktkapitalisatie van B uitslagen
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.
$2,174,951 $48.36M
$5.257T +10,869,221.10%
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.
$1,902,630 $48.36M
$4.599T +9,508,296.04%
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.
$1,699,043 $48.36M
$4.107T +8,490,870.59%
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.
$1,480,040 $48.36M
$3.577T +7,396,402.63%
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.
$1,161,485 $48.36M
$2.807T +5,804,420.71%